Preskoči na vsebino

Onkologija

Pretreatment Planning and Patient Optimization

Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. (odpre novo okno)

Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology.

Vir‎: Br J Anaesth 2014;113(3):416-23.

Indeksirano‎: PubMed 24829444

DOI‎: 10.1093/bja/aeu098

https://www.ncbi.nlm.nih.gov/pubmed/24829444 (odpre novo okno)

Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation. (odpre novo okno)

Bonello VA, Bhangu A, Fitzgerald JE, Rasheed S, Tekkis P.

Vir‎: Tech Coloproctol 2014;18(10):887-93.

Indeksirano‎: PubMed 24890577

DOI‎: 10.1007/s10151-014-1150-z

https://www.ncbi.nlm.nih.gov/pubmed/24890577 (odpre novo okno)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (odpre novo okno)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Vir‎: Ann Med Surg (Lond) 2016;6:6-11.

Indeksirano‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (odpre novo okno)

The theory and practice of bloodless surgery. (odpre novo okno)

Martyn V, Farmer SL, Wren MN, Towler SC, Betta J, Shander A, Spence RK, Leahy MF.

Vir‎: Transfus Apher Sci 2002;27(1):29-43.

Indeksirano‎: PubMed 12201468

https://www.ncbi.nlm.nih.gov/pubmed/12201468 (odpre novo okno)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes. (odpre novo okno)

Simou M, Thomakos N, Zagouri F, Vlysmas A, Akrivos N, Zacharakis D, Papadimitriou CA, Dimopoulos MA, Rodolakis A, Antsaklis A.

Vir‎: World J Surg Oncol 2011;9:142.

Indeksirano‎: PubMed 22051161

DOI‎: 10.1186/1477-7819-9-142

https://www.ncbi.nlm.nih.gov/pubmed/22051161 (odpre novo okno)

Effects of trilaciclib on chemotherapy-induced myelosuppression and patient-reported outcomes in patients with extensive-stage small cell lung cancer: Pooled results from three phase ii randomized, double-blind, placebo-controlled studies. (odpre novo okno)

Weiss J, Goldschmidt J, Andric Z, Dragnev KH, Gwaltney C, Skaltsa K, Pritchett Y, Antal JM, Morris SR, Daniel D

Vir‎: Clin Lung Cancer 2021;22(5):449-60. 

Indeksirano‎: PubMed 33895103

DOI‎: 10.1016/j.cllc.2021.03.010

https://pubmed.ncbi.nlm.nih.gov/33895103/ (odpre novo okno)

Adverse effects on hemostatic function of drugs used in hematologic malignancies. (odpre novo okno)

Zakarija A, Kwaan HC.

Vir‎: Semin Thromb Hemost 2007;33(4):355-64.

Indeksirano‎: PubMed 17525893

DOI‎: 10.1055/s-2007-976171

https://www.ncbi.nlm.nih.gov/pubmed/17525893 (odpre novo okno)